ARCA biopharma has an EPS of $-0.37. In 2022, the company made an earnings per share (EPS) of $-0.69. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.37 | -46.38% |
2022 | -$0.69 | -50.36% |
2021 | -$1.39 | -32.85% |
2020 | -$2.07 | - |